Literature DB >> 21227398

Δ-PCR, A Simple Method to Detect Translocations and Insertion/Deletion Mutations.

Ming-Tseh Lin1, Li-Hui Tseng, Roy G Rich, Michael J Hafez, Shuko Harada, Kathleen M Murphy, James R Eshleman, Christopher D Gocke.   

Abstract

PCR detection of chromosomal translocations and small insertion/deletion mutations is challenging when potential amplicon size varies greatly. Molecular diagnostic laboratories face such difficulties with the BCL2-IGH translocation in follicular lymphoma and with internal tandem duplication mutation of the FLT3 gene in leukemia, where breakpoints are widely distributed, mutations may be multiple, signal strength is low, and background noise is elevated. We developed a strategy, called Δ-PCR, that ensures PCR specificity and identifies individual breakpoints. Δ-PCR uses two forward primers (external and internal) and a reverse primer simultaneously. The internal primer functions as a probe with a defined distance Δ from the external primer. For follicular lymphoma, we prepared upstream, BCL2-specific primers for potential breakpoints to pair with a common, downstream VLJH primer. Multiplexed PCR amplicons are sized by capillary electrophoresis. Each of the upstream pairs has a defined interval separating them that uniquely identifies the breakpoint. The presence of two amplicons with a defined size difference confirms validity of the rearrangement and identity of the specific breakpoint, even if signal strength is low. By testing 40 follicular lymphoma and 12 control specimens from formalin-fixed, paraffin-embedded (FFPE) blocks, we showed that multiplex Δ-PCR is a simple, sensitive strategy to identify translocations with multiple breakpoints or partners. The strategy was also applied to detect minor leukemic clones with internal tandem duplication mutations and could have broader applications for other insertion/deletion and duplication mutations. Copyright Â
© 2011 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21227398      PMCID: PMC3069866          DOI: 10.1016/j.jmoldx.2010.11.004

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  45 in total

Review 1.  Detection of BCL2 rearrangements in follicular lymphoma.

Authors:  Jon C Aster; Janina A Longtine
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay.

Authors:  Kathleen M Murphy; Mark Levis; Michael J Hafez; Tanya Geiger; Lisa C Cooper; B Douglas Smith; Donald Small; Karin D Berg
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

3.  Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes.

Authors:  Y C Chen; J D Eisner; M M Kattar; S L Rassoulian-Barrett; K LaFe; S L Yarfitz; A P Limaye; B T Cookson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction.

Authors:  K D Berg; C L Glaser; R E Thompson; S R Hamilton; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

5.  Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course.

Authors:  C-C Chang; C Bredeson; M Juckett; B Logan; C A Keever-Taylor
Journal:  Bone Marrow Transplant       Date:  2003-08       Impact factor: 5.483

6.  Pseudo-spikes are common in histologically benign lymphoid tissues.

Authors:  S C Lee; K D Berg; F K Racke; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

7.  Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.

Authors:  J W Vaandrager; E Schuuring; T Raap; K Philippo; K Kleiverda; P Kluin
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

8.  Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

Authors:  Joshua Wechsler; Marianne Greene; Michael A McDevitt; John Anastasi; Judith E Karp; Michelle M Le Beau; John D Crispino
Journal:  Nat Genet       Date:  2002-08-12       Impact factor: 38.330

Review 9.  Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

Authors:  J Gabert; E Beillard; V H J van der Velden; W Bi; D Grimwade; N Pallisgaard; G Barbany; G Cazzaniga; J M Cayuela; H Cavé; F Pane; J L E Aerts; D De Micheli; X Thirion; V Pradel; M González; S Viehmann; M Malec; G Saglio; J J M van Dongen
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

10.  A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.

Authors:  M Ladetto; S Sametti; J W Donovan; D Ferrero; M Astolfi; M Mitterer; I Ricca; D Drandi; P Corradini; P Coser; A Pileri; J G Gribben; C Tarella
Journal:  Exp Hematol       Date:  2001-02       Impact factor: 3.084

View more
  8 in total

1.  Test Feasibility of Next-Generation Sequencing Assays in Clinical Mutation Detection of Small Biopsy and Fine Needle Aspiration Specimens.

Authors:  Gang Zheng; Harrison Tsai; Li-Hui Tseng; Peter Illei; Christopher D Gocke; James R Eshleman; George Netto; Ming-Tseh Lin
Journal:  Am J Clin Pathol       Date:  2016-05       Impact factor: 2.493

2.  Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma.

Authors:  Jonathan C Dudley; Grzegorz T Gurda; Li-Hui Tseng; Derek A Anderson; Guoli Chen; Janis M Taube; Christopher D Gocke; James R Eshleman; Ming-Tseh Lin
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

3.  Cytosine deamination is a major cause of baseline noise in next-generation sequencing.

Authors:  Guoli Chen; Stacy Mosier; Christopher D Gocke; Ming-Tseh Lin; James R Eshleman
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

4.  Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.

Authors:  Lisa Haley; Li-Hui Tseng; Gang Zheng; Jonathan Dudley; Derek A Anderson; Nilofer S Azad; Christopher D Gocke; James R Eshleman; Ming-Tseh Lin
Journal:  Mod Pathol       Date:  2015-07-31       Impact factor: 7.842

5.  Tandem duplication PCR: an ultrasensitive assay for the detection of internal tandem duplications of the FLT3 gene.

Authors:  Ming-Tseh Lin; Li-Hui Tseng; Katie Beierl; Antony Hsieh; Michele Thiess; Nadine Chase; Amanda Stafford; Mark J Levis; James R Eshleman; Christopher D Gocke
Journal:  Diagn Mol Pathol       Date:  2013-09

6.  Mutational profiling of colorectal cancers with microsatellite instability.

Authors:  Elaine I Lin; Li-Hui Tseng; Christopher D Gocke; Stacy Reil; Dung T Le; Nilofer S Azad; James R Eshleman
Journal:  Oncotarget       Date:  2015-12-08

7.  Clinical mutational profiling of 1006 lung cancers by next generation sequencing.

Authors:  Peter B Illei; Deborah Belchis; Li-Hui Tseng; Doreen Nguyen; Federico De Marchi; Lisa Haley; Stacy Riel; Katie Beierl; Gang Zheng; Julie R Brahmer; Frederic B Askin; Christopher D Gocke; James R Eshleman; Patrick M Forde; Ming-Tseh Lin
Journal:  Oncotarget       Date:  2017-05-20

8.  Clinical detection and categorization of uncommon and concomitant mutations involving BRAF.

Authors:  Gang Zheng; Li-Hui Tseng; Guoli Chen; Lisa Haley; Peter Illei; Christopher D Gocke; James R Eshleman; Ming-Tseh Lin
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.